Outcome After Radiotherapy Alone for Metastatic Spinal Cord Compression in Patients With Oligometastases
- 1 January 2007
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (1), 50-56
- https://doi.org/10.1200/jco.2006.08.7155
Abstract
Purpose: To investigate outcome and prognosis of metastatic spinal cord compression (MSCC) patients with oligometastatic disease treated with radiotherapy alone. Patients and Methods: Oligometastatic disease was defined as involvement of three or fewer vertebrae and lack of other bone or visceral metastases. Five hundred twenty-one patients with oligometastatic disease and MSCC were evaluated for functional outcome, ambulatory status, local control of MSCC, and survival. Furthermore, seven potential prognostic factors were investigated. Results: Motor function improved in 40% (n = 207), remained stable in 54% (n = 279), and deteriorated in 7% (n = 35) of patients. Fifty-eight (54%) of 107 nonambulatory patients became ambulatory, and 388 (94%) of 414 ambulatory patients remained ambulatory. Improved functional outcome was significantly associated with tumor type and slower development of motor deficits (> 14 days). Local control at 1, 2, and 3 years was 92%, 88%, and 78%, respectively. Improved local control was significantly associated with long-course radiotherapy. Survival at 1, 2, and 3 years was 71%, 58%, and 50%, respectively. Better survival was significantly associated with tumor type, ambulatory status, slower development of motor deficits, and long-course radiotherapy. Patients who developed motor deficits slowly (onset > 14 days before initiating treatment) were further analyzed. In this subgroup, the best results were observed for myeloma/lymphoma and breast cancer patients. No patient had progression of motor deficits. One hundred percent (myeloma/lymphoma) and 99% (breast cancer) of patients were ambulatory after radiotherapy. One-year local control was 100% and 98%, 1-year survival was 94% and 89%. Conclusion: Given the limitations of a retrospective review, improved outcome of patients with oligometastatic MSCC was associated with myeloma/lymphoma and breast cancer, slower development of motor deficits, and a more prolonged course of radiation.Keywords
This publication has 25 references indexed in Scilit:
- Prognostic Factors for Local Control and Survival After Radiotherapy of Metastatic Spinal Cord CompressionJournal of Clinical Oncology, 2006
- Extracranial Radiosurgery (Stereotactic Body Radiation Therapy) for OligometastasesSeminars in Radiation Oncology, 2006
- Physics and Imaging for Targeting of OligometastasesSeminars in Radiation Oncology, 2006
- Can decompressive surgery improve outcome in patients with metastatic epidural spinal-cord compression?Nature Clinical Practice Oncology, 2006
- Evaluation of Five Radiation Schedules and Prognostic Factors for Metastatic Spinal Cord CompressionJournal of Clinical Oncology, 2005
- Malignant spinal-cord compressionThe Lancet Oncology, 2005
- Zoledronic Acid Versus Placebo in the Treatment of Skeletal Metastases in Patients With Lung Cancer and Other Solid Tumors: A Phase III, Double-Blind, Randomized Trial—The Zoledronic Acid Lung Cancer and Other Solid Tumors Study GroupJournal of Clinical Oncology, 2003
- Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Experimental Analysis of the Spinal Cord Compressed by Spinal MetastasisSpine, 1989
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958